CAMP4 Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

2025202620262027
Price/Earnings ratio
1.78-10.62N/AN/A
Price/Sales ratio
0.240.200.200.20
Earnings per Share (EPS)
$0.95$-0.16N/AN/A

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
954.75904.61-1.87K1.14K601.04-94.02-438.48-183.78-109.12-2.94-3.44-3.44
Price/Sales ratio
62.8954.5838.1351.8430.3920.2330.0619.3512.021.470.4020.23
Price/Book Value ratio
104.1180.8881.6595.3753.7753.7097.5675.92247.80N/A6.1853.70
Price/Cash Flow ratio
550.22323.29519.10283.60231.63641.61324.54-1.35K-154.60N/A-3.93641.61
Price/Free Cash Flow ratio
743.16355.69750.86323.99309.46-695.60538.45-326.81-104.17N/A-2.77-2.77
Price/Earnings Growth ratio
27.05N/A13.05-3.4047.080.175.96-4.38-48.01-0.01-0.060.17
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
34.87%36.67%40.82%41.23%40.61%39.14%39.66%41.20%36.95%35.96%38.38%39.14%
Operating Profit Margin
9.95%10.00%0.38%2.17%5.41%-4.58%-1.25%-5.17%-7.28%-4.68%-8.45%-4.58%
Pretax Profit Margin
9.89%7.95%-1.98%7.84%6.55%-15.92%-6.67%-10.16%-10.62%-49.79%-11.47%-15.92%
Net Profit Margin
6.58%6.03%-2.03%4.54%5.05%-21.51%-6.85%-10.52%-11.01%-50.07%-11.79%-21.51%
Effective Tax Rate
33.43%20.46%15.76%37.20%-5.57%-35.07%-2.72%-3.61%-3.67%0.56%-2.75%-5.57%
Return on Assets
8.14%4.40%-1.75%3.51%3.04%-15.88%-4.87%-7.95%-8.54%N/A-8.63%-15.88%
Return On Equity
10.90%8.94%-4.36%8.35%8.94%-57.11%-22.25%-41.30%-227.09%N/A-92.95%-57.11%
Return on Capital Employed
16.02%8.38%0.40%2.10%3.78%-4.47%-1.18%-5.08%-7.85%N/A-8.58%-4.47%
Liquidity Ratios
Current Ratio
2.716.022.652.884.821.951.99N/AN/AN/A1.681.95
Quick Ratio
2.315.692.312.504.441.651.771.801.41N/A1.221.65
Cash ratio
0.722.811.221.383.060.880.880.870.39N/A0.410.88
Days of Sales Outstanding
69.7864.2770.0771.4078.3372.0574.9075.93102.64N/A112.4278.33
Days of Inventory outstanding
41.7434.3551.4461.6254.1260.2546.3938.3346.92N/A47.0060.25
Operating Cycle
111.5398.62121.51133.02132.45132.30121.29114.26149.56N/A74.72132.30
Days of Payables Outstanding
53.7051.2053.1760.2267.4046.6070.1166.75103.48N/A109.5467.40
Cash Conversion Cycle
57.8347.4268.3372.8065.0485.6951.1747.5046.08N/A14.4785.69
Debt Ratios
Debt Ratio
0.000.380.370.340.470.470.460.520.63N/A0.950.47
Debt Equity Ratio
0.000.770.940.821.381.702.142.7216.80N/A19.801.38
Long-term Debt to Capitalization
N/A0.420.470.430.570.590.670.720.94N/A0.920.57
Total Debt to Capitalization
0.000.430.480.450.580.620.680.730.94N/A0.920.58
Interest Coverage Ratio
346.383.690.010.771.65-0.82-0.22N/AN/AN/A-2.83-0.82
Cash Flow to Debt Ratio
41.630.320.160.400.160.040.14-0.02-0.09N/A-0.120.04
Company Equity Multiplier
1.332.022.482.372.933.594.565.1926.56N/A20.802.93
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.110.160.070.180.130.030.09-0.01-0.07N/A-0.100.03
Free Cash Flow / Operating Cash Flow Ratio
0.740.900.690.870.74-0.920.604.151.48N/A1.410.74
Cash Flow Coverage Ratio
41.630.320.160.400.160.040.14-0.02-0.09N/A-0.120.04
Short Term Coverage Ratio
41.636.953.246.305.420.346.62-1.63-32.52N/A-23.910.34
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A